XML 65 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
REPORTABLE SEGMENT INFORMATION (Tables)
12 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Information about domestic and international operations
Information about Ashland’s domestic and international operations follows.  Ashland has no operations in any individual international country or single customer that represented more than 10% of sales in 2017, 2016 or 2015.
 
Sales to
 
 
 
 
 
Property, plant
 
external customers
 
Net assets (liabilities)
 
and equipment - net
(In millions)
2017

 
2016

 
2015

 
2017

 
2016

 
2017

 
2016

United States
$
1,248

 
$
1,165

 
$
1,330

 
$
674

 
$
41

 
$
1,417

 
$
1,341

International
2,012

 
1,854

 
2,090

 
2,732

 
3,124

 
553

 
559

 
$
3,260

 
$
3,019

 
$
3,420

 
$
3,406

 
$
3,165

 
$
1,970

 
$
1,900

Revenue from External Customers by Products and Services [Table Text Block]
Ashland determined that disclosing sales by specific product was impracticable due to the highly customized and extensive portfolio of products offered to customers and since no one product or a small group of products could be aggregated together to represent a majority of revenue within a reportable segment. As such, the following table provides a summary of 2017 sales by product category for each reportable segment:
Sales by product category for 2017
Specialty Ingredients
 
Composites
 
Intermediates and Solvents
Cellulosics
36
%
 
UPR/VER (a)
83
%
 
Derivatives
61
%
Poly vinyl pyrrolidones
18
%
 
Gelcoats and other
17
%
 
Butanediol
39
%
Adhesives
15
%
 
 
100
%
 
 
100
%
Actives
6
%
 
 
 
 
 
 
Vinyl ethers
6
%
 
 
 
 
 
 
Pharmachem
5
%
 
 
 
 
 
 
Other
14
%
 
 
 
 
 
 
 
100
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 

(a)
UPR stands for unsaturated polyester resins and VER stands for vinyl ester resins.
Schedule of segment reporting information, by segment
Ashland Global Holdings Inc. and Consolidated Subsidiaries
 
 
 
 
 
Reportable Segment Information
 
 
 
 
 
Years Ended September 30
 
 
 
 
 
 
(In millions)
2017

 
2016

 
2015

Sales
 
 
 
 
 
Specialty Ingredients
$
2,216

 
$
2,089

 
$
2,263

Composites (a)
779

 
669

 
834

Intermediates and Solvents
265

 
261

 
323

 
$
3,260

 
$
3,019

 
$
3,420

Equity income
 

 
 

 
 

Specialty Ingredients
$

 
$

 
$
1

Composites

 
1

 
2

Intermediates and Solvents

 

 

Unallocated and other

 

 

 

 
1

 
3

Other income (expense)
 

 
 

 
 

Specialty Ingredients
(2
)
 
(1
)
 
(1
)
Composites
4

 
5

 
5

Intermediates and Solvents

 

 

Unallocated and other
5

 
3

 
8

 
7

 
7

 
12

 
$
7

 
$
8

 
$
15

Operating income (loss)
 

 
 

 
 

Specialty Ingredients
$
233

 
$
237

 
$
239

Composites
67

 
63

 
61

Intermediates and Solvents
(12
)
 
(181
)
 
26

Unallocated and other
(146
)
 
(246
)
 
(214
)
 
$
142

 
$
(127
)
 
$
112

Assets
 

 
 

 
 

Specialty Ingredients
$
6,050

 
$
5,235

 
$
5,365

Composites
586

 
520

 
711

Intermediates and Solvents
292

 
311

 
368

Unallocated and other
1,690

 
3,934

 
3,622

 
$
8,618

 
$
10,000

 
$
10,066

 
 
 
 
 
 
(a)
Fiscal 2015 includes $40 million of sales from the divested Elastomers division for the period October 1, 2014 through the completion of the sale on December 1, 2014. See Note D for more information.


Ashland Global Holdings Inc. and Consolidated Subsidiaries
 
 
 
 
 
Reportable Segment Information (continued)
 
 
 
 
 
Years Ended September 30
 
 
 
 
 
 
(In millions)
2017

 
2016

 
2015

Depreciation and amortization
 

 
 

 
 

Specialty Ingredients
$
243

 
$
243

 
$
244

Composites
22

 
22

 
27

Intermediates and Solvents
31

 
31

 
32

Unallocated and other
5

 
6

 
3

 
$
301

 
$
302

 
$
306

Property, plant and equipment - net
 

 
 

 
 

Specialty Ingredients
$
1,470

 
$
1,388

 
$
1,383

Composites
189

 
175

 
174

Intermediates and Solvents
146

 
160

 
184

Unallocated and other
165

 
177

 
188

 
$
1,970

 
$
1,900

 
$
1,929

Additions to property, plant and equipment
 

 
 

 
 

Specialty Ingredients
$
148

 
$
179

 
$
171

Composites
26

 
23

 
23

Intermediates and Solvents
10

 
13

 
10

Unallocated and other
15

 
16

 
16

 
$
199

 
$
231

 
$
220